Landmark debt deal enables commercial readiness for ITM-11, supports pipeline [...]

Biostate AI has raised $12 million in Series A funding [...]

Pharmaceutical innovation is at a critical inflection point. Most companies [...]

PhaseV has secured $50 million in Series A funding to [...]

BridgeBio Pharma has announced that the first participant has been [...]

Strategic collaboration combines advanced AAV-like particle technology with targeted oncology [...]

SOTIO’s lead candidate, SOT109, is generating buzz in the ADC [...]

As generative AI rapidly evolves, one of its most promising [...]